| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 159,820 | 141,915 | 96,416 | 143,548 | | Cost of Revenue | 124,484 | 110,899 | 71,390 | 107,728 | | | Gross Profit | 35,336 | 31,016 | 25,026 | 35,820 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 15,173 | 15,534 | 14,221 | 16,573 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 2,958 | 2,910 | 2,822 | 2,499 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 17,205 | 12,572 | 7,983 | 16,748 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 9,797 | 1,057 | 258 | 1,116 | | Earnings Before Interest And Taxes | 27,002 | 13,629 | 8,241 | 17,864 | | Interest Expense | 5,175 | 6,580 | 6,037 | 6,167 | | Income Before Tax | 21,827 | 7,049 | 2,204 | 11,697 | | Income Tax Expense | (145) | 551 | 202 | 476 | | Minority Interest | 47 |
-
|
-
| 2 | | | | Net Income From Continuing Ops | 22,019 | 6,498 | 2,002 | 11,223 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 22,019 | 6,498 | 2,002 | 11,223 | | Preferred Stock And Other Adjustments | (14) | 3 | 11 |
-
| | | Net Income Applicable To Common Shares | $22,005 | $6,501 | $2,013 | $11,223 |
|
0.51% Nasdaq 
Income Statement
